Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
NCT00842257Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2009
- Primary completion
- Dec 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal cancer (CRC), sponsored by Massachusetts General Hospital. Started May 2009; status: completed.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00842257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842257.